The 2026 ISPE Europe Annual Conference brings together pharmaceutical and biopharmaceutical professionals from all levels of the industry – from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment, and services, and global regulatory agencies.
This flagship event will explore how cutting-edge technologies, such as artificial intelligence and machine learning (AI/ML), virtual and augmented reality, and smart manufacturing, are reshaping our industry. We’ll also spotlight breakthroughs in biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs), and dive into practical strategies for addressing current challenges such as drug shortages and improving global access to medicines.
Participants will benefit from expert-led sessions on enhancing operational efficiency, ensuring project success, and sharing real-world case studies. Whether you’re here to discover emerging trends, contribute lessons learned, or benchmark best practices, the 2026 ISPE Europe Annual Conference offers a collaborative platform for driving innovation and excellence.
We look forward to your contribution and to collectively shaping the future of pharmaceutical and biopharmaceutical manufacturing at this year’s conference.
Navigate the conference platform via the listed links.

Join one of five interactive learning sessions designed to guide you through processes to gain a competitive advantage and ensure compliance.
- Drug Shortage Prevention
- Pharma Open Data Space: Turning Vision into Reality
- GMP Compliant Project Delivery
- Building a Sustainability Culture in Life Sciences Companies
- Quality Risk Management in the Light of New European Pharma Regulations

The pharmaceutical industry is currently facing significant challenges and opportunities that require constant re-evaluation of practices, options, and risk mitigation strategies. The intense environment and increasing complexity demand an adaptive approach to architecting the journey from molecule to product to patient solutions. Breaking with traditional thinking to adapt to new circumstances requires participation from every seat—internally and externally—always collaboratively.

This presentation provides an overview of recent activities within the GMDP Inspectors Working Group, including updates to GMP and GDP guidance, inspector training initiatives, and developments in reliance and international cooperation. It will outline ongoing work to strengthen traceability, improve oversight across the supply chain, and support consistent supervisory practices across EU and partner authorities.

This panel brings together leading regulators from the EMA, HPRA, and CBG-MEB (Dutch Medicines Evaluation Board) to explore how regulatory leadership can evolve in an era of rapid technological and scientific change. The discussion will explore current and emerging regulatory initiatives, including digital transformation efforts, GMP modernization, maturation of quality risk management frameworks, and early thinking on AI guidance, and assess whether these developments adequately support innovation while maintaining product quality and patient protection.
Use the hashtag #EAC and tag @ISPE in your posts highlighting your conference experience. Plus, follow the official hashtag #EAC to stay up to date on activities and events throughout the conference and include it in your social media posts.